GenovaX / Molecular research

Move from molecular question to reviewable evidence.

A concept-stage, non-clinical workflow for sequence, structure, literature and experimental-planning review. No therapy, patient use, diagnostic output or clinical enrollment is offered.

Design & PrototypeResearchPrototypeValidated

Current stage: Design & Prototype. GenovaX does not diagnose, treat, enroll patients, recommend clinical action, claim therapeutic efficacy or represent FDA clearance, approval, designation or authorization.

Technical overview

A molecular result is only as useful as its provenance.

GenovaX is designed to connect scientific questions, data sources, computational methods, assumptions, limitations and expert review in one traceable workflow.

Architecture 01

Sequence context

Organize sequence inputs, annotations, assumptions and data provenance for qualified review.

Architecture 02

Structure exploration

Support non-clinical visualization and hypothesis generation without implying experimental validation.

Architecture 03

Literature evidence

Connect claims to sources, study design, limitations and unresolved contradictions.

Architecture 04

Experiment planning

Translate hypotheses into reviewable, non-clinical validation plans for qualified laboratories.

Architecture 05

Data governance

Define permission, retention, consent and prohibited-data boundaries before analysis.

Architecture 06

Expert review

Require qualified scientific interpretation before findings are shared or advanced.

Evidence status

What exists—and what must still be proven.

A claim advances only when it has a dated method, test conditions, limitations and a reviewable result.

AreaCurrent statusPublic interpretation
Software workflowConcept and interface designNo validated production research platform is claimed.
Molecular predictionsNot experimentally validatedComputational outputs are hypotheses, not biological or therapeutic facts.
Clinical useNot permittedThe workflow is not a medical device, diagnostic system or treatment tool.
Regulatory statusNone claimedNo FDA or other regulatory clearance, approval or authorization is represented.
Laboratory resultsNone publicly validatedNo successful experiment, candidate therapy or patient outcome is claimed.

Development roadmap

Advance through evidence gates.

Scope expands only when technical evidence, safety review, resources and governance support the next stage.

01

Research question

Define the scientific question, source data, exclusions and decision boundaries.

Evidence gate
02

Traceable analysis

Run documented sequence, structure and literature workflows with visible assumptions.

Evidence gate
03

Expert review

Evaluate scientific plausibility, uncertainty, safety and alternative interpretations.

Evidence gate
04

Laboratory plan

Prepare a bounded non-clinical validation protocol with a qualified partner.

Evidence gate
05

Evidence update

Revise claims only after reproducible experimental results and independent review.

Evidence gate

Qualified collaboration

Turn the next technical question into evidence.

Planckchron is seeking collaborators in computational biology, structural biology, laboratory validation, research ethics, data governance and reproducibility. Do not submit patient data or confidential sequences through the public website.